Peer Review History
| Original SubmissionApril 7, 2022 |
|---|
|
PONE-D-22-10305The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending the child COVID-19 vaccination to parentsPLOS ONE Dear Dr. Kikut, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by two reviewers, and their comments are available below. The reviewers have raised a number of major concerns. They state that there is a general lack of detail regarding crucial aspects of the sample and the methodology, and raise concerns that the statistical analyses described in the manuscript are inadequate. Could you please carefully revise the manuscript to address all comments raised? Please submit your revised manuscript by Sep 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maria Elisabeth Johanna Zalm, Ph.D Editorial Office PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript reports on the results of an online study which employs an experimental design to test whether the presentation of COVID-19 vaccine information to parents, including source trustworthiness and evidence of vaccine efficacy, differentially and interactively impact self-reported intentions to vaccinate their child and belief regarding vaccine safety and efficacy for children. The topic is highly relevant, and the study design is novel. Additionally, the author is commended for pre-registering their hypotheses prior to data collection. However, there are significant concerns throughout the manuscript that need to be addressed. Briefly, these include a lack of appropriate scientific language, inadequate statistical analyses, and a general lack of detail regarding crucial aspects of the sample and methodology. Please see attached comments. Reviewer #2: The author addressed the problem of COVID-19 vaccination decision for children in the theoretical framework of dual-processing theory. The paper quotes mostly previous empirical researches related to the effects of 'evidence' and 'trustworthiness' with some theoretical literature related to dual processing theory, however it lacks the broader theoretical background of vaccine hesitancy. The empirical analysis based on experiment using online survey as a tool, said to be national probability sample. However the given source can not be assessed according to the applied sampling methodology (also the randomized experiment doesn't necessarily require probability sample). The author used descriptive statistics and ANOVA for analyzing data, however the paper doesn't include any tests for assumption of ANOVA, and it doesn't contain measures of effects. The author drove conclusions based on the statistical data and the previously quoted literature, however it also should address the generalizability of the current research The paper well structured. It contains two tables with descriptive statistics, which are also quoted in the text, while doesn't include result of the ANOVA analysis in table. The paper quotes 48 sources in the order of appearance. The strength of the paper is that it address an important problem, it is based on well-designed research and it has an important conclusion. However, the paper needs further improvement to be more evident. Major issues to be addressed by the author are the following: - further literature about vaccine hesitancy should be included, that embeds the current research in a broader context - sampling method should be clarified - tests for assumptions of ANOVA should be conducted and evaluated - a measure of effect size should also be reported in the case of ANOVA - the conclusion should include some thoughts about how the current results can be generalized Further minor issues: - I would advise combining descriptive statistics into one table, and including one further table with the results of the ANOVA - Title for tables should be revised to be more informative and according to APA rules - Wording of the paper should be checked, it would be better to avoid sentences in the first person ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-22-10305R1The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending the child COVID-19 vaccination to parentsPLOS ONE Dear Dr. Kikut, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please find Reviewer #3 comments below, containing several detailed points. I believe that you can swiftly address most of them to improve your manuscript. One of Reviewer #3 points, however, requires your special attention. It is related to the lack of preexisting vaccine beliefs measurement. Perhaps, in the light of that remark, it would be better to say about the effect of your IVs on vaccine beliefs, but not on persuasiveness, as you indeed do not evidence attitude changes. One more thing is how you formulate your hypotheses. I strongly suggest sticking to statistical - not causal - relationships. E.g., instead of saying "increase," it is better to say "positively related to." Statistical relationships are what you actually test in your study. Moreover, if you prefer to display your hypotheses in a separate section, clarify how they are based on your considerations in the preceding section. It will improve your communication, especially among readers who will not necessarily read your entire text. Please submit your revised manuscript by Jun 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Wojciech Trzebinski, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: The author reports on a the effect of different message framing strategies on perceived message effectiveness and pro-vaccine beliefs. This is an important topic of interest to a variety of disciplines. While I am enthusiastic about the topic, opportunities for improvement are detailed below. INTRODUCTION Great context regarding the pandemic at the time of data collection. 1. A citation is needed for lines 51-53. 2. “Literature review” heading (line 59) should be changed to better reflect the content of each section being reviewed. METHODS 3. Lines 169-171: Were there any group differences by period? Given the two phases, how did you ensure that participants did not complete the survey twice? 4. The exclusion of participants should be reported in the method section. The use of attention checks, or any other indicator of data quality (e.g., bot screening) should be reported. If these were not used, it should be noted as a limitation in the discussion section. 5. Given the lack of a priori power analysis, a sensitivity analysis should be conducted and reported in the method section. 6. Page starting on line 229: Because items for both measures were adapted from previous scales, specific information pertaining to how it was adapted (in text) and factor loadings (supplement is acceptable) should be reported. 7. Section beginning with Line 250: A more relevant subheading would be helpful. The following is unclear: 1) why are covariates not considered? Vaccination status of the child, age, and political affiliation are relevant to the outcomes based on the existing literature and warrant consideration. I appreciate that consideration of covariates was perhaps not pre-registered; however, one can certainly still conduct exploratory tests. And 2) randomizing order for assessing vaccine status does not control for social desirability bias in responding. The absence of measures pertaining to social desirability bias is a limitation to be briefly discussed. RESULTS 8. An exploratory section testing covariates is warranted. DISCUSSION 9. Lines 382-385: The study did not include an assessment of pre-message vaccine beliefs (which is a notable limitation). Thus, the claim that dual processing may play a role in shifting perceptions does not seem appropriate. 10. Childhood COVID-19 vaccine intention or uptake behavior are not assessed, and this is a limitation to be discussed given that the ultimate goal for health promotion messages is to increase uptake. OTHER 11. The author notes no financial disclosure; however, the author also notes “budget constraints” impacting the timing of recruitment periods (lines 169-171). The funding source for participant payment should be reported. 12. Line 471 (Acknowledgements) – If Robert Hornik and Diana Mutz “provided expertise and support throughout all aspects of this study”, why are they not co-authors? Reviewer #4: Interesting study looking at the relative contribution of trust and evidence to child COVID-19 vaccination beliefs. Substantive adjustments to the paper have been made, reviewer comments have been addressed in full and the manuscript is suitable for publication. Some minor writing errors still persist, but these can be identified through the final editorial stages. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending child COVID-19 vaccination to parents PONE-D-22-10305R2 Dear Dr. Kikut, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Wojciech Trzebiński, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): While completing the required amendments, please fix the following two minor issues: (1) make sure you use "interaction effect" consistently throughout the paper (in some places, you use "interactive effects") (2) make sure you use "pro-vaccination belief" when you refer to this measurement (in some places, you use just "belief," which may be unclear for readers). Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: The concerns have been adequately addressed. Thank you. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-22-10305R2 The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending child COVID-19 vaccination to parents Dear Dr. Kikut: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Wojciech Trzebiński Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .